Discontinued — last reported Q4 '17
Non-Current Assets
Goodwill
Bristol-Myers Squibb Goodwill decreased by 0.1% to $21.75B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.0%, from $21.75B to $21.75B. Over 4 years (FY 2020 to FY 2024), Goodwill shows relatively stable performance with a 1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2017
How to read this metric
High goodwill indicates a history of aggressive M&A; significant write-downs signal that acquired assets are underperforming expectations.
Detailed definition
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Peer comparison
Common in industries with high M&A activity; peers are compared based on the ratio of goodwill to total equity.
Metric ID:
goodwillHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.53B | $20.52B | $20.50B | $20.50B | $20.45B | $21.11B | $21.15B | $21.16B | $21.16B | $21.15B | $21.17B | $21.74B | $21.73B | $21.75B | $21.72B | $21.74B | $21.78B | $21.75B |
| QoQ Change | — | -0.0% | -0.1% | -0.0% | -0.3% | +3.3% | +0.2% | +0.1% | +0.0% | -0.1% | +0.1% | +2.7% | -0.0% | +0.1% | -0.1% | +0.1% | +0.2% | -0.1% |
| YoY Change | — | — | — | — | -0.4% | +2.9% | +3.2% | +3.2% | +3.5% | +0.2% | +0.1% | +2.7% | +2.7% | +2.9% | +2.6% | -0.0% | +0.2% | -0.0% |
Range$20.45B – $21.78B
CAGR+1.4%
Avg YoY Growth+1.7%
Median YoY Growth+2.6%
Goodwill at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's goodwill?
- Bristol-Myers Squibb (BMY) reported goodwill of $21.75B in Q3 2025.
- How has Bristol-Myers Squibb's goodwill changed year-over-year?
- Bristol-Myers Squibb's goodwill decreased by 0.0% year-over-year, from $21.75B to $21.75B.
- What is the long-term trend for Bristol-Myers Squibb's goodwill?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's goodwill has grown at a 1.4% compound annual growth rate (CAGR), from $20.55B to $21.72B.
- What does goodwill mean?
- The premium paid for an acquisition above the value of its tangible and identifiable assets.